191 related articles for article (PubMed ID: 34508669)
1. Health-care provision and policy for non-alcoholic fatty liver disease in sub-Saharan Africa.
Spearman CW; Abdo A; Ambali A; Awuku YA; Kassianides C; Lesi OA; Ndomondo-Sigonda M; Onyekwere CA; Rwegasha J; Shewaye AB; Sonderup MW;
Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):1047-1056. PubMed ID: 34508669
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology, risk factors, social determinants of health, and current management for non-alcoholic fatty liver disease in sub-Saharan Africa.
Spearman CW; Afihene M; Betiku O; Bobat B; Cunha L; Kassianides C; Katsidzira L; Mekonnen HD; Ocama P; Ojo O; Paruk I; Tzeuton C; Sonderup MW;
Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):1036-1046. PubMed ID: 34508671
[TBL] [Abstract][Full Text] [Related]
3. Burden of non-communicable diseases in sub-Saharan Africa, 1990-2017: results from the Global Burden of Disease Study 2017.
Gouda HN; Charlson F; Sorsdahl K; Ahmadzada S; Ferrari AJ; Erskine H; Leung J; Santamauro D; Lund C; Aminde LN; Mayosi BM; Kengne AP; Harris M; Achoki T; Wiysonge CS; Stein DJ; Whiteford H
Lancet Glob Health; 2019 Oct; 7(10):e1375-e1387. PubMed ID: 31537368
[TBL] [Abstract][Full Text] [Related]
4. Differentials in prevalence and correlates of metabolic risk factors of non-communicable diseases among women in sub-Saharan Africa: evidence from 33 countries.
Yaya S; Ekholuenetale M; Bishwajit G
BMC Public Health; 2018 Oct; 18(1):1168. PubMed ID: 30309337
[TBL] [Abstract][Full Text] [Related]
5. Integrating care for non-communicable diseases into routine HIV services: key considerations for policy design in sub-Saharan Africa.
Kintu A; Sando D; Okello S; Mutungi G; Guwatudde D; Menzies NA; Danaei G; Verguet S
J Int AIDS Soc; 2020 Jun; 23 Suppl 1(Suppl 1):e25508. PubMed ID: 32562370
[TBL] [Abstract][Full Text] [Related]
6. The COVID-19 Pandemic and Non-communicable Diseases-A Wake-up Call for Primary Health Care System Strengthening in Sub-Saharan Africa.
Kraef C; Juma P; Kallestrup P; Mucumbitsi J; Ramaiya K; Yonga G
J Prim Care Community Health; 2020; 11():2150132720946948. PubMed ID: 32734822
[TBL] [Abstract][Full Text] [Related]
7. COVID-19: implications for NCDs and the continuity of care in Sub-Saharan Africa.
Owopetu O; Fasehun LK; Abakporo U
Glob Health Promot; 2021 Jun; 28(2):83-86. PubMed ID: 33579179
[TBL] [Abstract][Full Text] [Related]
8. Burden of non-communicable diseases from infectious causes in 2017: a modelling study.
Coates MM; Kintu A; Gupta N; Wroe EB; Adler AJ; Kwan GF; Park PH; Rajbhandari R; Byrne AL; Casey DC; Bukhman G
Lancet Glob Health; 2020 Dec; 8(12):e1489-e1498. PubMed ID: 33098769
[TBL] [Abstract][Full Text] [Related]
9. Things must not fall apart: the ripple effects of the COVID-19 pandemic on children in sub-Saharan Africa.
Coker M; Folayan MO; Michelow IC; Oladokun RE; Torbunde N; Sam-Agudu NA
Pediatr Res; 2021 Apr; 89(5):1078-1086. PubMed ID: 32971527
[TBL] [Abstract][Full Text] [Related]
10. Noncommunicable Disease (NCD) strategic plans in low- and lower-middle income Sub-Saharan Africa: framing and policy response.
Boudreaux C; Noble C; Coates MM; Kelley J; Abanda M; Kintu A; McLaughlin A; Marx A; Bukhman G
Glob Health Action; 2020 Dec; 13(1):1805165. PubMed ID: 32873212
[TBL] [Abstract][Full Text] [Related]
11. Research needs for an improved primary care response to chronic non-communicable diseases in Africa.
Maher D; Sekajugo J; Harries AD; Grosskurth H
Trop Med Int Health; 2010 Feb; 15(2):176-81. PubMed ID: 20002618
[TBL] [Abstract][Full Text] [Related]
12. The post-2015 development agenda for diabetes in sub-Saharan Africa: challenges and future directions.
Renzaho AM
Glob Health Action; 2015; 8():27600. PubMed ID: 25994288
[TBL] [Abstract][Full Text] [Related]
13. A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe.
Lazarus JV; Ekstedt M; Marchesini G; Mullen J; Novak K; Pericàs JM; Roel E; Romero-Gómez M; Ratziu V; Tacke F; Cortez-Pinto H; Anstee QM;
J Hepatol; 2020 Jan; 72(1):14-24. PubMed ID: 31518646
[TBL] [Abstract][Full Text] [Related]
14. [Advances in diagnosis and treatment of nonalcoholic fatty liver disease].
Zhu C; Zhou D; Fan J
Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):81-4. PubMed ID: 26983471
[TBL] [Abstract][Full Text] [Related]
15. Building on the HIV chronic care platform to address noncommunicable diseases in sub-Saharan Africa: a research agenda.
Vorkoper S; Kupfer LE; Anand N; Patel P; Beecroft B; Tierney WM; Ferris R; El-Sadr WM;
AIDS; 2018 Jul; 32 Suppl 1(Suppl 1):S107-S113. PubMed ID: 29952796
[TBL] [Abstract][Full Text] [Related]
16. Integrating diabetes, hypertension and HIV care in sub-Saharan Africa: a Delphi consensus study on international best practice.
McCombe G; Murtagh S; Lazarus JV; Van Hout MC; Bachmann M; Jaffar S; Garrib A; Ramaiya K; Sewankambo NK; Mfinanga S; Cullen W
BMC Health Serv Res; 2021 Nov; 21(1):1235. PubMed ID: 34781929
[TBL] [Abstract][Full Text] [Related]
17. Controlling diabetes and hypertension in sub-Saharan Africa: lessons from HIV programmes.
Jaffar S; Ramaiya K; Karekezi C; Sewankambo N;
Lancet; 2021 Sep; 398(10306):1111-1113. PubMed ID: 34506744
[No Abstract] [Full Text] [Related]
18. Tackling an emerging epidemic: the burden of non-communicable diseases among people living with HIV/AIDS in sub-Saharan Africa.
Achwoka D; Mutave R; Oyugi JO; Achia T
Pan Afr Med J; 2020; 36():271. PubMed ID: 33088400
[TBL] [Abstract][Full Text] [Related]
19. Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD).
O'Gorman P; Norris S
BMJ Open Gastroenterol; 2021 Jun; 8(1):. PubMed ID: 34168043
[TBL] [Abstract][Full Text] [Related]
20. [Non-alcoholic fatty liver disease (NAFLD)].
Rau M; Weiss J; Geier A
Dtsch Med Wochenschr; 2015 Jul; 140(14):1051-5. PubMed ID: 26182253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
